CLINICAL_TRIALS
trial_result
· 2013-08-07
Clinical Trial Update: The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule [Phase 4]
Summary
A Phase 4 trial evaluating DengzhanShengmai Capsule for secondary prevention after ischemic stroke has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Guangzhou University of Traditional Chinese Medicine | Conditions: Stroke | Phase 4 | Status: COMPLETED